Joined Cambium August 2013. President, CEO of 3Ti (automated blood analyzer start-up) 2006-16. CEO of Refocus Group (ophthalmic device start-up) 2002-05. CMO of Autonomous Technologies (refractive surgery start-up) from 1994-98. SVP-Sales & Marketing and Business Development at CIBA Vision (Novartis) 1988-98. Director VirtualScopics (public medical imaging software company) 2006-16. BS-Indiana, MBA-Notre Dame.
Jacques Galipeau, MD FRCP(C)
Professor Hematology & Medical Oncology,— Director of the University of Wisconsin Advanced Cell Therapy Program, Associate Dean for Therapeutics Development all at The University of Wisconsin. Georgia Cancer Coalition Distinguished Cancer Scholar. MD-University of Montreal.
John D. Roback, MD, PhD
Director Center for Transfusion & Cellular Therapies, Medical Director Emory University Hospital Blood Bank & Emory Healthcare School of Medical Technology. Co-author of leading text book in Transfusion Medicine. Chief Scientific Advisor, Co-Founder of 3Ti (automated blood analyzer) 2000-16. Has authored, co-authored numerous NIH STTR and DOD grants. National Blood Foundation Scholar. BS-Johns Hopkins, MD & PhD-Chicago.
Edmund K. Waller, MD, PhD
Professor of Medicine, Pathology & Hematology/Oncology, Associate Director Winship Cancer Institute, Director of Division of Stem Cell Transplantation & Immunotherapy and Bone Marrow & Stem Cell Transplant Centers, Medical Director of Center for Apheresis and Stem Cell Processing Lab—all at Emory University. BS-Harvard, MD-Cornell, PhD-Rockefeller University.
IN MEMORY - Ian Copland, PhD
Spent 15 years in medical research, primarily cellular therapies. Assistant Professor of Medicine, Hematology & Lab Director Personalized Immunotherapy Center, Emory University. Faculty Member Parker H. Petit Institute for Bioengineering & Bioscience at Georgia Tech. Director of Regenerative Medicine at AccelLAB 2008-10. 20 published papers. PhD-University of Toronto. 1973-2015.